Author

H. Ueki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

K. Iwatsuki-Horimoto· 3 shared M. Imai· 3 shared M. Ito· 3 shared Y. Kawaoka· 3 shared S. Yamayoshi· 2 shared T. Maemura· 2 shared Y. Furusawa· 2 shared Y. Hirata· 2 shared

Activity by Year

2022-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

K. Iwatsuki-Horimoto

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Can SARS-CoV-2 transmit from a dead body?

K. Iwatsuki-Horimoto, H. Ueki, M. Ito, S. Nagasawa, Y. Hirata, K. Hashizume, K. Ushiwata, H. Iwase, Y. Makino, T. Ushiku, S. Akitomi, M. Imai, H. Saitoh, Y. Kawaoka

This study investigates SARS-CoV-2 transmission from dead bodies using a hamster model, finding that transmission is possible but can be prevented by postmortem care and embalming.

bioRxiv · Aug 29, 2022 · PreprintMicrobiology

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

R. Uraki, S. Iida, P. J. Halfmann, S. Yamayoshi, Y. Hirata, K. Iwatsuki-Horimoto, M. Kiso, M. Ito, Y. Furusawa, H. Ueki, Y. Sakai-Tagawa, M. Kuroda, T. Maemura, T. Kim, S. Mine, , Y. Kawaoka

This study evaluates the replicative ability and pathogenicity of SARS-CoV-2 BA.2.75 isolates in Syrian hamsters, finding higher lung replication and focal pneumonia compared to BA.2 and BA.5.

bioRxiv · Aug 26, 2022 · PreprintMicrobiology

Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models.

M. Takeshita, H. Fukuyama, K. Kamada, T. Matsumoto, C. Makino-Okamura, T. Uchikubo-Kamo, Y. Tomabechi, K. Hanada, S. Moriyama, Y. Takahashi, H. Ishigaki, M. Nakayama, C. T. Nguyen, Y. Kitagawa, Y. Itoh, , T. Takeuchi

The paper develops Fc-modified SARS-CoV-2 neutralizing antibodies effective against variants, showing reduced viral titers and lung damage in animal models.

bioRxiv · Jun 21, 2022 · PreprintMicrobiology